These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37696083)

  • 1. Molecular mechanisms of Thrombospondin-2 modulates tumor vasculogenic mimicry by PI3K/AKT/mTOR signaling pathway.
    Huang J; Wang C; Hou Y; Tian Y; Li Y; Zhang H; Zhang L; Li W
    Biomed Pharmacother; 2023 Nov; 167():115455. PubMed ID: 37696083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Celastrol Suppresses Glioma Vasculogenic Mimicry Formation and Angiogenesis by Blocking the PI3K/Akt/mTOR Signaling Pathway.
    Zhu Y; Liu X; Zhao P; Zhao H; Gao W; Wang L
    Front Pharmacol; 2020; 11():25. PubMed ID: 32116702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-expressed B7-H3 promotes vasculogenic mimicry formation rather than angiogenesis in non-small cell lung cancer.
    Fan X; Huang J; Hu B; Zhou J; Chen L
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):8729-8741. PubMed ID: 37129607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxazosin inhibits vasculogenic mimicry in human non‑small cell lung cancer through inhibition of the VEGF‑A/VE‑cadherin/mTOR/MMP pathway.
    Hsu JL; Leu WJ; Hsu LC; Hsieh CH; Guh JH
    Oncol Lett; 2024 Apr; 27(4):170. PubMed ID: 38455663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Class I histone deacetylase inhibitor suppresses vasculogenic mimicry by enhancing the expression of tumor suppressor and anti-angiogenesis genes in aggressive human TNBC cells.
    Maiti A; Qi Q; Peng X; Yan L; Takabe K; Hait NC
    Int J Oncol; 2019 Jul; 55(1):116-130. PubMed ID: 31059004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Inhibition of the FGFR/PI3K/Akt Axis by AZD4547 Disrupts the Proangiogenic Microenvironment and Vasculogenic Mimicry Arising from the Interplay between Endothelial and Triple-Negative Breast Cancer Cells.
    Morales-Guadarrama G; Méndez-Pérez EA; García-Quiroz J; Avila E; Ibarra-Sánchez MJ; Esparza-López J; García-Becerra R; Larrea F; Díaz L
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of Vasculogenic Mimicry in Ovarian Cancer.
    Ayala-Domínguez L; Olmedo-Nieva L; Muñoz-Bello JO; Contreras-Paredes A; Manzo-Merino J; Martínez-Ramírez I; Lizano M
    Front Oncol; 2019; 9():998. PubMed ID: 31612116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments.
    Wei X; Chen Y; Jiang X; Peng M; Liu Y; Mo Y; Ren D; Hua Y; Yu B; Zhou Y; Liao Q; Wang H; Xiang B; Zhou M; Li X; Li G; Li Y; Xiong W; Zeng Z
    Mol Cancer; 2021 Jan; 20(1):7. PubMed ID: 33397409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD36 promotes vasculogenic mimicry in melanoma by mediating adhesion to the extracellular matrix.
    Martini C; DeNichilo M; King DP; Cockshell MP; Ebert B; Dale B; Ebert LM; Woods A; Bonder CS
    BMC Cancer; 2021 Jul; 21(1):765. PubMed ID: 34215227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of compound DMBT on hypoxia-induced vasculogenic mimicry in human breast cancer.
    Li S; Zhang Q; Zhou L; Guan Y; Chen S; Zhang Y; Han X
    Biomed Pharmacother; 2017 Dec; 96():982-992. PubMed ID: 29208325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Luteolin Suppresses Three Angiogenesis Modes and Cell Interaction in Uveal Melanoma
    Chen YF; Wu S; Li X; Chen M; Liao HF
    Curr Eye Res; 2022 Dec; 47(12):1590-1599. PubMed ID: 36214596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylase 3 expression correlates with vasculogenic mimicry through the phosphoinositide3-kinase / ERK-MMP-laminin5γ2 signaling pathway.
    Liu X; Wang JH; Li S; Li LL; Huang M; Zhang YH; Liu Y; Yang YT; Ding R; Ke YQ
    Cancer Sci; 2015 Jul; 106(7):857-66. PubMed ID: 25940092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelium-Dependent Induction of Vasculogenic Mimicry in Human Triple-Negative Breast Cancer Cells Is Inhibited by Calcitriol and Curcumin.
    Morales-Guadarrama G; Méndez-Pérez EA; García-Quiroz J; Avila E; García-Becerra R; Zentella-Dehesa A; Larrea F; Díaz L
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Mechanisms and Anticancer Therapeutic Strategies in Vasculogenic Mimicry.
    Zhang X; Zhang J; Zhou H; Fan G; Li Q
    J Cancer; 2019; 10(25):6327-6340. PubMed ID: 31772665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-1β Promotes Vasculogenic Mimicry of Breast Cancer Cells Through p38/MAPK and PI3K/Akt Signaling Pathways.
    Nisar MA; Zheng Q; Saleem MZ; Ahmmed B; Ramzan MN; Ud Din SR; Tahir N; Liu S; Yan Q
    Front Oncol; 2021; 11():618839. PubMed ID: 34055597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory mechanisms and therapeutic targeting of vasculogenic mimicry in hepatocellular carcinoma.
    Zheng N; Zhang S; Wu W; Zhang N; Wang J
    Pharmacol Res; 2021 Apr; 166():105507. PubMed ID: 33610718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Overview of Vasculogenic Mimicry in Breast Cancer.
    Andonegui-Elguera MA; Alfaro-Mora Y; Cáceres-Gutiérrez R; Caro-Sánchez CHS; Herrera LA; Díaz-Chávez J
    Front Oncol; 2020; 10():220. PubMed ID: 32175277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular regulation of vasculogenic mimicry in tumors and potential tumor-target therapy.
    Fan YZ; Sun W
    World J Gastrointest Surg; 2010 Apr; 2(4):117-27. PubMed ID: 21160860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of transgelin blocks interleukin-8 utilization and suppresses vasculogenic mimicry in breast cancer cells.
    Aikins AR; Kim M; Raymundo B; Kim CW
    Exp Biol Med (Maywood); 2017 Mar; 242(6):573-583. PubMed ID: 28058861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. cRGD-functionalized nanoparticles for combination therapy of anti-endothelium dependent vessels and anti-vasculogenic mimicry to inhibit the proliferation of ovarian cancer.
    Wang Y; Tong L; Wang J; Luo J; Tang J; Zhong L; Xiao Q; Niu W; Li J; Zhu J; Chen H; Li X; Wang Y
    Acta Biomater; 2019 Aug; 94():495-504. PubMed ID: 31252171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.